Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Vanguard Emerging Markets Gover | VWOB | Jan 8, 2025 | 63.30 | +0.11 |
Vanguard International Dividend Appreciation ETF | VIGI | Jan 8, 2025 | 80.46 | +0.01 |
Vanguard International High Dividend Yield ETF | VYMI | Jan 8, 2025 | 68.26 | -0.15 |
Vanguard Short-Term Inflation-P | VTIP | Jan 8, 2025 | 48.50 | +0.10 |
Vanguard Total International Bo | BNDX | Jan 8, 2025 | 48.74 | -0.18 |
Varex Imaging | VREX | Jan 8, 2025 | 13.85 | -2.33 |
Varonis Systems | VRNS | Jan 8, 2025 | 44.24 | -0.16 |
Vast Renewables | VSTE | Jan 8, 2025 | 1.14 | -6.17 |
Vasta Platform | VSTA | Jan 8, 2025 | 2.30 | -3.36 |
Vaxart | VXRT | Jan 8, 2025 | 0.81 | -7.64 |
Vaxcyte | PCVX | Jan 8, 2025 | 81.06 | -7.14 |
VCI Global | VCIG | Jan 8, 2025 | 1.73 | -1.14 |
Veea | VEEA | Jan 8, 2025 | 3.67 | -2.39 |
Veeco Instruments | VECO | Jan 8, 2025 | 28.15 | -1.57 |
Veeva Systems A | VEEV | Jan 8, 2025 | 217.30 | +2.63 |
Velocity Financial | VEL | Jan 8, 2025 | 18.89 | -0.53 |
Ventas | VTR | Jan 8, 2025 | 58.27 | +2.10 |
Ventyx Biosciences | VTYX | Jan 8, 2025 | 2.25 | -10.71 |
Venu Holding | VENU | Jan 8, 2025 | 9.58 | 0.00 |
Venus Concept | VERO | Jan 8, 2025 | 0.38 | -17.21 |
Veon ADR | VEON | Jan 8, 2025 | 44.60 | -1.28 |
Vera Bradley | VRA | Jan 8, 2025 | 3.60 | -6.49 |
Vera Therapeutics A | VERA | Jan 8, 2025 | 42.19 | +0.21 |
Veracyte | VCYT | Jan 8, 2025 | 43.78 | +3.04 |
Veralto | VLTO | Jan 8, 2025 | 102.00 | +0.34 |
Verastem | VSTM | Jan 8, 2025 | 5.90 | -9.79 |
Verb Technology | VERB | Jan 8, 2025 | 6.33 | -10.09 |
Verde Clean Fuels | VGAS | Jan 8, 2025 | 3.73 | -0.53 |
Veren | VRN | Jan 8, 2025 | 5.44 | -0.91 |
Vericel | VCEL | Jan 8, 2025 | 59.53 | +2.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.